DealBook reports that many on Wall Street are experiencing a heavy dose of schadenfreude at the demise of New York Governor Eliot Spitzer's political career. After all, this is a guy who made his name as the "sheriff of Wall Street," conducting a high-profile campaign of charges and settlements that exposed widespread malfeasance in the financial markets.
Disgraced former analyst Henry Blodget, who was exposed as a shill for investment bankers, posted a New York Post story on Spitzer's downfall on his blog, and other enemies Spitzer made during his anti-corruption crusade are coming out of the woodwork to cast their stones.
But here's the thing: the fact that Eliot Spitzer has a fondness for unsafe sex with $5000 prostitutes doesn't make Henry Blodget any less of a cheater, nor does it detract from the tremendous public good that Spitzer did in exposing self-serving shenanigans in the New York financial district -- even if his motives and character were less than pure.
Spitzer was 100% right when he said in his brief statement that "politics in the long run is about individuals. It is about ideas, the public good and doing what's best for the state of New York."
As Herb Greenberg wrote on his blog, this scandal is an "absolutely pathetic end to a brilliant career."
Let's not allow a prostitution ring to distract us from the need to expose corruption on Wall Street
Last updated: February 10, 2010: 10:16 AM
Hot Stocks
DailyFinance Headlines
- Toyota Chief Resignation Watch: Why Toyoda Will Stay CEO
- Daily Blogwatch: Which Countries Could Go Bankrupt? Which Companies?
- Dubai Debt Problems Resurface, QE II May Go on the Block
- Beer and Bone Study a Boon for Microbrews?
- Stocks in the News: Disney, Sprint, ArcelorMittal
TheFlyOnTheWall.com Headlines
- MotorolaVentures invests in Zenverge
- Dean Foods: Rising butterfat costs hurt Morningstar's Q4 results, will hurt Q1
- Intermune March volatility at 230, April at 192 into meeting
- Pacific Asia Petroleum raises $20M in a registered direct offeirng
- Hospira announces expiration of HSR review period
BioHealth Investor Headlines
- Cell Therapeutics Facing Tougher FDA (CTIC)
- New Restless Leg Syndrome Review for XenoPort (XNPT, GSK)
- AMAG Fights Back (AMAG)
- Human Genome Sciences… When Insiders Sell Stock (HGSI)
- 10-Bagger Hunt Heads Back to Repros (RPRX)
WalletPop Headlines
- Dinner for under $15: Mao Poe tofu by Buddakan NYC's Lon Symensma
- Looking for a job? Better be healthy, and best not to smoke
- Forget tax break when you donate vacation home stays to charities
- Local GM, Chrysler dealers fight to stay open
- CVS.com 25% off code on Twitter
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Money
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Dow Jones Industrial Average
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
- Zhu Zhu Pets
- Small Business Checking Account
- Crib Recall


